Simian adenovirus and hybrid adenoviral vectors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 12, 2020
Grant Date -
Jan 4, 2018
app pub date -
Jun 20, 2017
filing date -
May 25, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Recombinant adenoviral vectors, immunogenic compositions thereof and their use in medicine, and methods for generating recombinant adenoviral vectors are provided. In particular, the an adenovirus vector having a capsid derived from chimpanzee adenovirus AdY25, wherein the capsid encapsidates a nucleic acid molecule comprising an exogeneous nucleotide sequence of interest are provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully